Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 14
2003 15
2004 23
2005 34
2006 29
2007 33
2008 31
2009 39
2010 54
2011 64
2012 68
2013 94
2014 96
2015 109
2016 117
2017 136
2018 186
2019 211
2020 242
2021 269
2022 164
Text availability
Article attribute
Article type
Publication date

Search Results

1,791 results
Results by year
Filters applied: . Clear all
Page 1
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study.
Kuruvilla J, Ramchandren R, Santoro A, Paszkiewicz-Kozik E, Gasiorowski R, Johnson NA, Fogliatto LM, Goncalves I, de Oliveira JSR, Buccheri V, Perini GF, Goldschmidt N, Kriachok I, Dickinson M, Komarnicki M, McDonald A, Ozcan M, Sekiguchi N, Zhu Y, Nahar A, Marinello P, Zinzani PL; KEYNOTE-204 investigators. Kuruvilla J, et al. Among authors: zhu y. Lancet Oncol. 2021 Apr;22(4):512-524. doi: 10.1016/S1470-2045(21)00005-X. Epub 2021 Mar 12. Lancet Oncol. 2021. PMID: 33721562 Clinical Trial.
Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition.
Zhou L, He R, Fang P, Li M, Yu H, Wang Q, Yu Y, Wang F, Zhang Y, Chen A, Peng N, Lin Y, Zhang R, Trilling M, Broering R, Lu M, Zhu Y, Liu S. Zhou L, et al. Among authors: zhu y. Nat Commun. 2021 Jan 4;12(1):98. doi: 10.1038/s41467-020-20316-8. Nat Commun. 2021. PMID: 33397935 Free PMC article.
Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway.
Zhang D, Huang J, Sun X, Chen H, Huang S, Yang J, Du X, Tan Q, Luo F, Zhang R, Zhou S, Jiang W, Ni Z, Wang Z, Jin M, Xu M, Li F, Chen L, Liu M, Su N, Luo X, Yin L, Zhu Y, Feng JQ, Chen D, Qi H, Chen L, Xie Y. Zhang D, et al. Among authors: zhu y. Nat Commun. 2021 Jul 19;12(1):4391. doi: 10.1038/s41467-021-24643-2. Nat Commun. 2021. PMID: 34282140 Free PMC article.
Multisystem inflammation and susceptibility to viral infections in human ZNFX1 deficiency.
Vavassori S, Chou J, Faletti LE, Haunerdinger V, Opitz L, Joset P, Fraser CJ, Prader S, Gao X, Schuch LA, Wagner M, Hoefele J, Maccari ME, Zhu Y, Elakis G, Gabbett MT, Forstner M, Omran H, Kaiser T, Kessler C, Olbrich H, Frosk P, Almutairi A, Platt CD, Elkins M, Weeks S, Rubin T, Planas R, Marchetti T, Koovely D, Klämbt V, Soliman NA, von Hardenberg S, Klemann C, Baumann U, Lenz D, Klein-Franke A, Schwemmle M, Huber M, Sturm E, Hartleif S, Häffner K, Gimpel C, Brotschi B, Laube G, Güngör T, Buckley MF, Kottke R, Staufner C, Hildebrandt F, Reu-Hofer S, Moll S, Weber A, Kaur H, Ehl S, Hiller S, Geha R, Roscioli T, Griese M, Pachlopnik Schmid J. Vavassori S, et al. Among authors: zhu y. J Allergy Clin Immunol. 2021 Aug;148(2):381-393. doi: 10.1016/j.jaci.2021.03.045. Epub 2021 Apr 17. J Allergy Clin Immunol. 2021. PMID: 33872655 Free PMC article. Clinical Trial.
Meloxicam-Induced Pancreatitis.
Landa E, Ganim I, Vigandt E, Siraj T, Zhu Y. Landa E, et al. Among authors: zhu y. Cureus. 2021 Jan 28;13(1):e12976. doi: 10.7759/cureus.12976. Cureus. 2021. PMID: 33654637 Free PMC article.
1,791 results